| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.058 | 0.06 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.06 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.066 | 0.06 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.07 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.07 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.068 | 0.07 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.056 | 0.07 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.07 |